These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38498034)

  • 1. Malignant progression of preleukemic disorders.
    Hall T; Gurbuxani S; Crispino JD
    Blood; 2024 May; 143(22):2245-2255. PubMed ID: 38498034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
    Rupniewska ZM
    Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
    [No Abstract]   [Full Text] [Related]  

  • 3. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
    Ueda K; Ikeda K
    Fukushima J Med Sci; 2024 Jan; 70(1):11-24. PubMed ID: 37952978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].
    Kreipe HH
    Pathologe; 2011 Nov; 32 Suppl 2():271-6. PubMed ID: 22033685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
    Schaefer EJ; Lindsley RC
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
    Lin TL; Nagata Y; Kao HW; Sanada M; Okuno Y; Huang CF; Liang DC; Kuo MC; Lai CL; Lee EH; Shih YS; Tanaka H; Shiraishi Y; Chiba K; Lin TH; Wu JH; Miyano S; Ogawa S; Shih LY
    Haematologica; 2014 Jan; 99(1):28-36. PubMed ID: 23996483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.
    Valent P; Kern W; Hoermann G; Milosevic Feenstra JD; Sotlar K; Pfeilstöcker M; Germing U; Sperr WR; Reiter A; Wolf D; Arock M; Haferlach T; Horny HP
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male predominance in AML is associated with specific preleukemic mutations.
    De-Morgan A; Meggendorfer M; Haferlach C; Shlush L
    Leukemia; 2021 Mar; 35(3):867-870. PubMed ID: 32576964
    [No Abstract]   [Full Text] [Related]  

  • 11. A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes.
    Preisler HD
    Cancer Genet Cytogenet; 1988 May; 32(1):133-42. PubMed ID: 3162703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood myelodysplastic syndrome.
    Chatterjee T; Choudhry VP
    Indian J Pediatr; 2013 Sep; 80(9):764-71. PubMed ID: 23912822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.
    Kotini AG; Chang CJ; Chow A; Yuan H; Ho TC; Wang T; Vora S; Solovyov A; Husser C; Olszewska M; Teruya-Feldstein J; Perumal D; Klimek VM; Spyridonidis A; Rampal RK; Silverman L; Reddy EP; Papaemmanuil E; Parekh S; Greenbaum BD; Leslie CS; Kharas MG; Papapetrou EP
    Cell Stem Cell; 2017 Mar; 20(3):315-328.e7. PubMed ID: 28215825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer and myeloid clonal evolution in the short telomere syndromes.
    Schratz KE; Armanios M
    Curr Opin Genet Dev; 2020 Feb; 60():112-118. PubMed ID: 32276199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preleukemic disorders].
    Yoshida Y; Oguma S; Uchino H
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):149-55. PubMed ID: 2645830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.
    Cada M; Segbefia CI; Klaassen R; Fernandez CV; Yanofsky RA; Wu J; Pastore Y; Silva M; Lipton JH; Brossard J; Michon B; Abish S; Steele M; Sinha R; Belletrutti M; Breakey V; Jardine L; Goodyear L; Sung L; Shago M; Beyene J; Sharma P; Zlateska B; Dror Y
    Haematologica; 2015 May; 100(5):633-42. PubMed ID: 25682607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.
    Kao HW; Sanada M; Liang DC; Lai CL; Lee EH; Kuo MC; Lin TL; Shih YS; Wu JH; Huang CF; Ogawa S; Shih LY
    Neoplasia; 2011 Nov; 13(11):1035-42. PubMed ID: 22131879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What biologic factors predict for transformation to AML?
    Bejar R
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):341-345. PubMed ID: 30466744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
    Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
    Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.